Developing methods to remove palladium from drug manufacturing processes
Official title: Removal of Palladium from Pharmaceutical Process Chemistry Reactions
Funded at Palladias LLC · NIH-11065868 · Data updated 2026-11-12
This study is working on finding affordable and reusable materials that can help remove palladium, a metal used in making some medicines, to make sure your medications are safer and cleaner.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Palladias LLC NIH-funded |
| Lab location | 1 site (Los Alamos, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $280,160 |
| NIH project number | 1R43GM157773-01 |
| Project ID | NIH-11065868 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include patients who rely on medications developed through palladium-catalyzed processes.
✕Less likely to help
Patients who are not using medications that involve palladium in their synthesis may not benefit from this research.
What this research studies
This research focuses on creating cost-effective and reusable materials that can efficiently remove palladium from pharmaceutical products. Palladium is commonly used as a catalyst in drug synthesis, but its removal from final products poses challenges. By employing high-throughput screening techniques, the project aims to identify and develop specialized sorbents that can selectively extract palladium from drug compounds. This could enhance the safety and efficacy of medications by ensuring they are free from harmful metal residues.
Why it matters
Potential benefit: If successful, this research could lead to safer pharmaceuticals with reduced metal contamination, improving patient health outcomes.
How similar studies have gone: Previous research has shown promise in developing methods for removing metal catalysts from pharmaceutical products, indicating a potential for success in this approach.
Where this research is happening
-
Palladias LLC
Los Alamos, United States Active
Researchers
- Principal investigator: Warner, Benjamin P — Palladias LLC
- Study coordinator: Warner, Benjamin P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.